PREFERENTIAL Study

Status Withdrawn

Clinical Trial Summary

To determine patient preference for the dexamethasone insert or topical prednisolone therapy through at Day 45 as measured by - Modified COMTOL survey.

Clinical Trial Description

Eyes from 80 patients will be randomized in a 1:1 ratio to the assigned treatment, dexamethasone insert placed at the time of surgery, or topical prednisolone acetate 1% therapy prescribed on a tapering dose schedule post-operatively. Males and Females 18 years and older with 1)Presence of a visually significant cataract with plans to undergo clear cornea cataract surgery with phacoemulsification and implantation of a posterior chamber intraocular lens (IOL), and potential postoperative Snellen pinhole corrected distance visual acuity (CDVA) of at least 20/200 in both eyes and 2) 10 patients with mild-to-moderate primary open angle glaucoma and a visually significant cataract with plans to undergo clear cornea cataract surgery with phacoemulsification and implantation of a posterior chamber Intraocular Len (IOL) combined with a Minimally Invasive Glaucoma Surgery (MIGS) procedure in both eyes. Study visits will consist of eye exam with ocular photos from an Optical Coherence Tomography (OCT). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04563559
Study type	Interventional
Source	Duke University
Contact
Status	Withdrawn
Phase	Phase 2/Phase 3
Start date	November 2020
Completion date	November 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02573610` - Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery	Phase 3
Completed	`NCT02910362` - Intra-surgical Evaluation of CATS Tonometer Prism and Abbott Medical Optics Versus Alcon Phacoemulsification Machines	N/A
Recruiting	`NCT01193504` - Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification	Phase 4
Completed	`NCT01455233` - 2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract Surgery	Phase 4
Completed	`NCT01199510` - Efficacy Evaluation of SYSTANE® ULTRA in Patients Scheduled for Cataract Surgery	Phase 4
Completed	`NCT04146961` - The PanOptix Trifocal IOL: A Study of Patient Satisfaction, Visual Disturbances, and Uncorrected Visual Performance
Completed	`NCT00585975` - Efficacy and Safety of Bromfenac Ophthalmic Solution	Phase 2
Completed	`NCT00406913` - Prophylaxis Prior to Cataract Surgery Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery	N/A
Not yet recruiting	`NCT04131335` - Use of Prophylactic Lubricating Drops After Cataract Surgery	N/A
Recruiting	`NCT05331690` - Cataract Surgery and Inflammation - the Role for Preoperative NSAIDs (Pre-CIN)	Phase 4
Completed	`NCT04732351` - Evaluation of the Active Sentry System During Cataract Surgery With the Centurion Phacoemulsifier
Completed	`NCT02128113` - RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD	Phase 2
Completed	`NCT03873454` - The Effects of Music on Perioperative Outcomes in Cataract Surgery	N/A
Completed	`NCT04769856` - Impact of Non-fasting on Anxiety in Cataract Surgery	N/A
Withdrawn	`NCT00604305` - Comperative Trial Between an Accommodative Iol and Monofocal Iol	N/A
Completed	`NCT05925894` - Efficacy Mydrane ® for Cataract Surgery in Patients With Concomitant Primary Open Angle Glaucoma.	N/A
Not yet recruiting	`NCT06136780` - Impact of Free Reading Glasses on Work and Visual Function Following Cataract Surgery in Honduras	N/A
Completed	`NCT04633954` - Brimonidine for Subconjunctival Hemorrhage From Femtosecond Laser Assisted Cataract Surgery	N/A
Completed	`NCT03644875` - Study of Etacoat in Patients With Cataract Surgery Via the Anterior Chamber
Recruiting	`NCT04781231` - Impact of Music Added to the Usual Treatment on the Anxiety of Patients Undergoing Outpatient Cataract Surgery With Topical Anesthesia	N/A